Antifungals
also: fluconazole · nystatin · amphotericin · azole · terbinafine
Overview
Antifungals for candidiasis, dermatophytes and invasive fungal infection. The azole CYP interactions and amphotericin nephrotoxicity are key.
Mechanism
Azoles inhibit ergosterol synthesis (lanosterol 14α-demethylase, CYP-dependent). Polyenes (amphotericin/nystatin) bind ergosterol → membrane pores. Terbinafine inhibits squalene epoxidase.
The agents
oral/IV
Candida (vaginal single 150 mg), cryptococcal; CYP inhibitor (warfarin/statins); teratogenic high-dose; QT.
Oral/perioral candida (not absorbed).
Invasive fungal infection; "ampho-terrible" — nephrotoxicity, hypokalaemia, infusion reactions.
oral
Onychomycosis; hepatotoxic — check LFTs (cross-ref derm).
Adverse effects
Cautions & contraindications
Teratogenic.
CYP inhibition.
Interactions
- Azoles inhibit CYP3A4 (statins, warfarin, DOACs, calcineurin inhibitors)
Monitoring & kinetics
LFTs (oral azoles/terbinafine); U&E/Mg (amphotericin)
Topical for localised; oral/IV for systemic.
Choosing it
Spectrum: Azoles (fluconazole): Candida, Cryptococcus. Polyenes (nystatin topical; amphotericin systemic): broad. Terbinafine: dermatophytes (cross-ref derm).
Source: BNF — Antifungals